Qiyi Luo - MicroPort Scientific Chief Officer
| MCRPF Stock | USD 0.81 0.03 3.85% |
Executive
Mr. Qiyi Luo is Chief Technology Officer of MicroPort Scientific Corporationration Mr. Luo has served as a Director since July 22, 2010. Mr. Luo has over 19 years of experience in medical device industry. Prior to joining the company in 2003, he worked as principal research and development engineer and senior manufacturingdevelopment engineer at Medtronic AVE in the United States from 1995 to 2002. From 1991 to 1995, he worked as supervisor and engineer of the angioplasty research and development team at VasCath Inc., a subsidiary of C.R. Bard, Inc., in Canada. Mr. Luo, jointly with others, holds 30 patents and has 52 patent applications pending in China, the United States, Japan and the European Union since 2012.
| Age | 61 |
| Tenure | 12 years |
| Phone | 86 21 3895 4600 |
| Web | https://www.microport.com |
MicroPort Scientific Management Efficiency
The company has return on total asset (ROA) of (0.0705) % which means that it has lost $0.0705 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.25) %, meaning that it generated substantial loss on money invested by shareholders. MicroPort Scientific's management efficiency ratios could be used to measure how well MicroPort Scientific manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| FACC MD | Nuwellis | N/A | |
| Ryan McSeveney | Bluejay Diagnostics | N/A | |
| Ruth Hembree | Vivos Therapeutics | N/A | |
| Eric Dasso | Alphatec Holdings | 51 | |
| Indranil Dey | Bluejay Diagnostics | 61 | |
| John Ballard | Vivos Therapeutics | N/A | |
| Ali Shorooghi | Alphatec Holdings | 37 | |
| Luiz Pimenta | Alphatec Holdings | N/A | |
| Paul Wotta | Nuwellis | 67 | |
| Nicholas DeGennaro | Vivos Therapeutics | N/A | |
| Kimberly Bambach | Tivic Health Systems | 53 | |
| John Kowalczyk | Nuwellis | N/A | |
| Robert Scott | Nuwellis | 43 | |
| Joseph Walland | Alphatec Holdings | 45 | |
| Stephanie Huebner | Vivos Therapeutics | N/A | |
| Lisa Wolf | Tivic Health Systems | 61 | |
| Eryn Graham | Bluejay Diagnostics | N/A | |
| FACC MBA | Nuwellis | N/A | |
| Tyson Marshall | Alphatec Holdings | 50 | |
| Vitaliy Epshteyn | Nuwellis | 46 | |
| Les DeLuca | Bluejay Diagnostics | N/A | |
Management Performance
| Return On Equity | -0.25 | |||
| Return On Asset | -0.0705 |
MicroPort Scientific Leadership Team
Elected by the shareholders, the MicroPort Scientific's board of directors comprises two types of representatives: MicroPort Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MicroPort. The board's role is to monitor MicroPort Scientific's management team and ensure that shareholders' interests are well served. MicroPort Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MicroPort Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Qiyi Luo, Chief Officer | ||
| Jonathan Chen, Sr. VP of International Operation and Investor Relations | ||
| Kongrong Pan, VP Shanghai | ||
| Zhaohua Chang, Founder, Chairman, CEO and Member of Remuneration Committee | ||
| FCS FCIS, Company Sec | ||
| Yan Zhang, Pres Shanghai | ||
| Junder Chiang, Chief HR Officer | ||
| Hongbin Sun, Chief Officer | ||
| Glendy Wang, Chief Officer |
MicroPort Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is MicroPort Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.25 | |||
| Return On Asset | -0.0705 | |||
| Profit Margin | (0.48) % | |||
| Operating Margin | (0.53) % | |||
| Current Valuation | 4.92 B | |||
| Shares Outstanding | 1.82 B | |||
| Shares Owned By Insiders | 49.14 % | |||
| Shares Owned By Institutions | 17.84 % | |||
| Price To Earning | 217.50 X | |||
| Price To Book | 3.51 X |
Currently Active Assets on Macroaxis
Other Information on Investing in MicroPort Pink Sheet
MicroPort Scientific financial ratios help investors to determine whether MicroPort Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MicroPort with respect to the benefits of owning MicroPort Scientific security.